CRDL CIK: 1702123

Cardiol Therapeutics Inc.

  • Canada
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions CAD
FY21:
87.1
FY22:
61.4
FY23:
36.2
FY24:
31.7
FY25:
23.5
(positive)
Change from FY21 to FY25
millions CAD
FY21:
0.74
FY22:
0.59
FY23:
0.55
FY24:
0.20
FY25:
0.12
Total assets
Change from FY21 to FY25
millions CAD
FY21:
87.9
FY22:
62.0
FY23:
36.7
FY24:
31.9
FY25:
23.6

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions CAD
FY21:
11.6
FY22:
9.80
FY23:
8.30
FY24:
7.01
FY25:
5.66
(negative)
Change from FY21 to FY25
millions CAD
FY21:
0.07
FY22:
0.02
FY23:
0.16
FY24:
0.13
FY25:
0.09
(positive)
Change from FY21 to FY25
millions CAD
FY21:
76.2
FY22:
52.2
FY23:
28.2
FY24:
24.7
FY25:
17.9
Total liabilities & equity
Change from FY21 to FY25
millions CAD
FY21:
87.9
FY22:
62.0
FY23:
36.7
FY24:
31.9
FY25:
23.6

All amounts in millions CAD Data source:SEC EDGAR